• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Nuclear Imaging Devices Market Analysis

    ID: MRFR/HC/6542-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Nuclear Imaging Devices Market Research Report By Application (Cardiology, Oncology, Neurology, Thyroid Function), By Product Type (Single Photon Emission Computed Tomography, Positron Emission Tomography, Hybrid Imaging Systems), By End Use (Hospitals, Diagnostic Centers, Research Institutions), By Technology (Cobalt-60, Technetium-99m, Gallium-68) and By Regional (North America, Europe, South...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Nuclear Imaging Devices Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Nuclear Imaging Devices Market Industry Landscape

    The market dynamics of nuclear imaging devices are characterized by continuous advancements in medical technology and increasing prevalence of chronic diseases. Nuclear imaging plays a crucial role in diagnosing and monitoring various medical conditions, driving the demand for these devices. The world wide rise in chronic diseases such as cancer and cardiovascular problems has vastly led to the development of the nuclear imaging devices market. Such hardware assists in early identification, accurate identification, and efficient treatment of such situations for a growing acceptance. Technological advancements and subsequent advances in the field of nuclear imaging have driven the market tremendously. Improvements in the resolution of imaging, coincidently lowering radiation exposure and the emergence of hybrid imaging, such as PET/ CT, has improved the accuracy and speed of diagnostic techniques. With the increasing aged population of the world, age-related diseases have become furthermore common which doesn’t allow to use simply today’s standard tools. The aging population formulates a niche market for imaging devices and nuclear imaging devices are used in diagnosing condition which are occurring more in the elderly thus driving the market. Many governments and private sector bodies are spending hefty amounts to improve the healthcare infrastructure, especially in th erection of newer generation imaging apparatus. This increased from infrastructure development is beneficial not only for the nuclear imaging devices market but for the market itself as it allows for accessibility and affordability. With improved consciousness in the medics as well as patients of the advantages of nuclear imaging, demand has also enhanced. With an increasing appreciation of the benefits of early ac- curate diagnosis, the market for nuclear imaging devices is likely to experience continued growth. The regulatory landscape and reimbursement factors come into play when naming the forces influencing the dynamics of the nuclear imaging devices market. Rigorous regulatory standards guarantee safety and efficacy of these devices, also favorable reimbursement policies assist uptake. There is an increasing trend of industry – academic – healthcare partnerships. Such alliances promote the growth of novel technologies and the diffusion of market range outlets, contributing to the competitive and dynamic market. Although the development trends are favorable, factors of limitations are high initial setup costs, apprehensions regarding radiation exposure and availability of other diagnostic modalities can slow down the market growth to a greater extent. Though this challenge of sustaining strong market growth need to be dealt with by looking into research and development, it seems that these issues would remain pressing ones. The nuclear imaging devices market is poised for further growth with ongoing research, technological advancements, and a focus on personalized medicine. The integration of artificial intelligence in nuclear imaging is a notable trend, promising to enhance diagnostic accuracy and efficiency in the coming years.

    Market Summary

    The Global Nuclear Imaging Devices Market is projected to grow from 1.98 USD Billion in 2024 to 3.17 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Nuclear Imaging Devices Key Trends and Highlights

    • The market valuation is expected to reach 3.17 USD Billion by 2035, indicating a substantial increase from 3.36 USD Billion in 2024.
    • A compound annual growth rate (CAGR) of 3.68% is anticipated for the period between 2025 and 2035.
    • The growth in the market is likely driven by advancements in imaging technology and increasing demand for accurate diagnostic tools.
    • Growing adoption of nuclear imaging devices due to the rising prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.98 (USD Billion)
    2035 Market Size 3.17 (USD Billion)
    CAGR (2025-2035) 4.38%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Astellas Pharma, Northwestern Medicine, United Imaging Healthcare, Esaote, ZONARE, Mindray, Hitachi Healthcare, GE Healthcare, Canon Medical Systems, Siemens Healthineers, Philips, Neusoft Medical Systems, Toshiba, Bruker

    Market Trends

    The Nuclear Imaging Devices Market is witnessing significant trends, driven by technological advancements and increasing healthcare demands. The rise in chronic diseases and the aging global population are key market drivers. This results in a greater need for accurate diagnostic imaging techniques.

    Countries are investing heavily in healthcare infrastructure, supporting the integration of advanced nuclear imaging technologies. These technologies offer enhanced imaging quality and improved patient outcomes. This investment is crucial for market development and patient care.

    Moreover, there is a growing trend towards the use of hybrid imaging systems, which combine nuclear imaging with other modalities, such as CT and MRI. This fusion provides more comprehensive data, facilitating better diagnosis and treatment planning.

    Furthermore, the safety and efficacy of procedures are being enhanced by developments in molecular imaging and radiopharmaceuticals. This is why healthcare providers and patients are increasingly choosing nuclear imaging solutions, reflecting growing confidence in these technologies.

    Manufacturers have numerous prospects in the global market, particularly in the context of expanding into emerging regions. A conducive environment for growth is provided by the growing number of diagnostic centers and hospitals in developing countries.

    In order to improve service delivery and accessibility, organizations may consider forming partnerships with regional healthcare providers. These collaborations can help overcome logistical challenges and expand market reach in underserved areas.

    Moreover, the emphasis on personalized medicine is generating a demand for innovative imaging solutions. These are customized to the unique requirements of each patient, thereby facilitating research and development initiatives for tailored treatments.

    In recent years, the regulatory environment has also undergone a transformation, thereby fostering a more conducive environment for innovation. Manufacturers are compelled to improve their products and cultivate a competitive market in response to changes in safety and efficiency standards.

    In general, these trends have a significant impact on the Nuclear Imaging Devices Market. This presents both challenges and significant potential for development in the healthcare sector, driving continuous advancements.

    The Global Nuclear Imaging Devices Market is poised for growth as advancements in technology and increasing demand for early disease detection drive innovation and investment in this sector.

    U.S. Food and Drug Administration (FDA)

    Nuclear Imaging Devices Market Market Drivers

    Market Growth Projections

    The Global Nuclear Imaging Devices Market Industry is projected to experience substantial growth over the coming years. The market is anticipated to reach a valuation of 3.36 USD Billion in 2024, with expectations to expand to 5 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 3.68% from 2025 to 2035. Factors contributing to this upward trend include technological advancements, increasing prevalence of chronic diseases, and rising geriatric populations. These elements collectively indicate a robust future for the nuclear imaging sector, underscoring its critical role in modern healthcare.

    Technological Advancements

    The Global Nuclear Imaging Devices Market Industry is experiencing a surge in technological advancements, particularly in imaging techniques and equipment. Innovations such as hybrid imaging systems, which combine nuclear imaging with other modalities like CT or MRI, enhance diagnostic accuracy and patient outcomes. For instance, the integration of artificial intelligence in image analysis is streamlining workflows and improving detection rates. As these technologies evolve, they are expected to drive market growth, contributing to an estimated market value of 3.36 USD Billion in 2024, with projections indicating a rise to 5 USD Billion by 2035.

    Rising Geriatric Population

    The Global Nuclear Imaging Devices Market Industry is also driven by the rising geriatric population, which is more susceptible to various health issues requiring advanced diagnostic imaging. As the global population ages, the demand for nuclear imaging devices is expected to increase, as these tools are essential for diagnosing age-related diseases. The World Health Organization indicates that the number of individuals aged 60 and above is projected to double by 2050, suggesting a substantial market opportunity. This demographic shift is likely to contribute to a compound annual growth rate of 3.68% from 2025 to 2035, further enhancing market dynamics.

    Growing Awareness and Acceptance

    The Global Nuclear Imaging Devices Market Industry benefits from growing awareness and acceptance of nuclear imaging technologies among healthcare professionals and patients. Increased education on the advantages of nuclear imaging, such as its non-invasive nature and ability to provide functional information about organs, is fostering greater utilization. As healthcare providers recognize the value of these diagnostic tools, the demand is likely to rise. This trend is expected to contribute to the market's growth trajectory, with projections indicating a compound annual growth rate of 3.68% from 2025 to 2035, reflecting the evolving landscape of medical imaging.

    Government Initiatives and Funding

    Government initiatives and funding play a pivotal role in shaping the Global Nuclear Imaging Devices Market Industry. Various health authorities are investing in advanced imaging technologies to improve healthcare outcomes. For example, funding programs aimed at enhancing diagnostic capabilities in hospitals and clinics are becoming more prevalent. Such initiatives not only facilitate the adoption of nuclear imaging devices but also promote research and development in this field. As a result, the market is expected to witness robust growth, with an anticipated increase from 3.36 USD Billion in 2024 to 5 USD Billion by 2035, driven by supportive policies and financial backing.

    Increasing Prevalence of Chronic Diseases

    The Global Nuclear Imaging Devices Market Industry is significantly influenced by the rising prevalence of chronic diseases, such as cancer and cardiovascular disorders. These conditions necessitate advanced diagnostic tools for effective management and treatment planning. Nuclear imaging devices, including PET and SPECT, play a crucial role in early detection and monitoring of these diseases. The growing patient population requiring such diagnostics is likely to propel the market forward, aligning with the projected growth from 3.36 USD Billion in 2024 to 5 USD Billion by 2035, reflecting the increasing demand for precise imaging solutions.

    Market Segment Insights

    Nuclear Imaging Devices Market Application Insights

    The Nuclear Imaging Devices Market exhibits a diverse segmentation focused on Application. This includes critical areas such as Cardiology, Oncology, Neurology, and Thyroid Function. Cardiology holds a prominent position, valued at 1.0 USD Billion, rising to 1.5 USD Billion by 2035.

    This indicates the growing need for advanced imaging techniques to diagnose cardiovascular diseases. Oncology was valued at 1.2 USD Billion in 2024, expected to increase to 1.8 USD Billion in 2035, emphasizing its significance in cancer detection and monitoring.

    Neurology, valued at 0.8 USD Billion in 2024 and projected to reach 1.2 USD Billion by 2035, highlights the escalating importance of neuroimaging for diagnosis and treatment of neurological disorders. This segment reflects critical advancements in brain health.

    Thyroid Function, although the smallest segment at 0.36 USD Billion in 2024, is anticipated to grow to 0.5 USD Billion by 2035. This underlines the essential role of nuclear imaging in understanding thyroid conditions.

    The substantial revenue contributions from these applications demonstrate the relevance of nuclear imaging devices in enhancing diagnostic accuracy, improving patient outcomes, and fostering advancements in the medical industry. These insights are crucial for market analysis.

    Furthermore, market growth is driven by rising prevalence of chronic diseases, increasing investments in healthcare infrastructure, and technological advancements. Overall, the Nuclear Imaging Devices Market segmentation by Application showcases diverse opportunities, with Cardiology and Oncology being major contributors, reflecting their pivotal roles in addressing critical health challenges worldwide.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Nuclear Imaging Devices Market Product Type Insights

    The Nuclear Imaging Devices Market encompasses a variety of product types that are integral to the healthcare and medical imaging sectors. In 2024, the market is expected to be valued at 3.36 billion USD, reflecting the growing adoption of advanced imaging solutions globally.

    Within this segmentation, Single Photon Emission Computed Tomography and Positron Emission Tomography are critical components, known for their ability to provide detailed functional imaging. These technologies play a key role in diagnosing and monitoring conditions such as cancer and heart disease, thereby driving market growth.

    Hybrid Imaging Systems are also gaining prominence, as they combine different imaging modalities to enhance diagnostic accuracy and patient outcomes. With increased research and development in this sector, these product types are positioned to benefit from ongoing technological advancements.

    The Nuclear Imaging Devices Market data highlights a trend toward integrated solutions that streamline workflows in clinical settings. However, challenges such as regulatory hurdles and high equipment costs may impact accessibility and implementation in various regions.

    Nevertheless, opportunities for expansion exist, driven by rising healthcare investments and the demand for more precise diagnostic tools. The market's future looks favorable, underscoring the significance of these product types in improving healthcare delivery and patient care globally.

    Nuclear Imaging Devices Market End Use Insights

    The Nuclear Imaging Devices Market is experiencing noteworthy growth, particularly within the End Use segment. This segment includes key areas such as Hospitals, Diagnostic Centers, and Research Institutions.

    By 2024, the market is expected to be valued at 3.36 billion USD, signifying a robust demand for nuclear imaging technologies in various healthcare settings. Hospitals represent a crucial component of this market, as they are the primary providers of nuclear imaging services.

    They are responsible for detecting and diagnosing complex medical conditions. Diagnostic Centers are also significant, providing specialized imaging services that cater to patient needs and supporting clinical decision-making.

    Furthermore, Research Institutions play a vital role in advancing nuclear imaging methodologies, often driving innovation through clinical studies and trials. Their contributions are essential for the future of the field.

    The combination of these sectors highlights the increasing importance of nuclear imaging devices in enhancing patient care and facilitating groundbreaking medical research. The Nuclear Imaging Devices Market data reveals a steady interest in advanced imaging technologies.

    Nuclear Imaging Devices Market Technology Insights

    The Nuclear Imaging Devices Market, focusing on the Technology segment, is poised for notable growth as it adapts to the evolving medical landscape. By 2024, the market is projected to achieve a valuation of 3.36 USD Billion.

    This reflects the increasing demand for non-invasive diagnostic tools that utilize advanced imaging technologies. Among the various technologies, Cobalt-60, Technetium-99m, and Gallium-68 are pivotal due to their effectiveness and widespread utilization in diagnostic imaging.

    Technetium-99m, in particular, dominates the market as it plays a crucial role in more than 80% of nuclear medicine procedures. It provides essential insights in oncology, cardiology, and neurology, making it highly versatile.

    Cobalt-60 is integral in radiation therapy, enhancing treatment efficacy. Gallium-68 is gaining momentum for its applications in positron emission tomography PET, offering high-resolution imaging that aids in personalized treatment plans and disease staging.

    The overall growth of the Nuclear Imaging Devices Market is driven by advances in technology, increasing prevalence of chronic diseases, and rising healthcare expenditure globally, alongside regulatory support enhancing the market’s expansion.

    However, challenges such as high costs and limited accessibility in remote areas may hinder market penetration. This presents opportunities for innovation and development to improve reach and affordability in underserved regions, ensuring broader access to crucial diagnostics.

    Get more detailed insights about Nuclear Imaging Devices Market Research Report - Forecast till 2035

    Regional Insights

    The Nuclear Imaging Devices Market exhibits a diverse regional landscape, with North America commanding a significant portion of the market. Valued at 1.179 USD Billion in 2024 and projected to grow to 1.803 USD Billion by 2035, North America holds the majority.

    This is driven by advancements in technology and a strong healthcare infrastructure. Europe follows with a valuation of 0.801 USD Billion in 2024, increasing to 1.23 USD Billion in 2035, showcasing a robust demand for diagnostic imaging.

    South America, while smaller, is gaining ground with a value of 0.193 USD Billion in 2024 and an expected rise to 0.287 USD Billion by 2035. This reflects improving healthcare access and investment in medical technology.

    The Asia Pacific region, valued at 0.663 USD Billion in 2024, is projected to reach 1.025 USD Billion by 2035. This indicates a growing emphasis on medical technology investments and increasing healthcare awareness.

    Lastly, the Middle East and Africa are valued at 0.524 USD Billion in 2024 with an upward projection to 0.656 USD Billion by 2035. This highlights emerging markets seeking advanced medical solutions and infrastructure development.

    Overall, the Nuclear Imaging Devices Market segmentation underscores the varying growth potentials across regions. Established markets are leading, and emerging territories are gradually enhancing their footprint in the industry, reflecting global expansion.

    Nuclear Imaging Devices Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Nuclear Imaging Devices Market is characterized by rapid advancements in technology, increasing investment in research and development, and a rising demand for imaging services. This is primarily due to the growing incidence of chronic diseases worldwide.

    The market involves numerous players, ranging from established firms to new entrants. All are competing to improve and innovate their offerings. The competitive landscape is shaped by factors such as the development of advanced imaging systems, strategic partnerships, and acquisitions.

    It is also influenced by the expansion of operational capacities to meet the growing needs of healthcare providers. Additionally, the global emphasis on precision medicine and the use of nuclear imaging in therapeutic applications further intensifies the competition among market players.

    Astellas Pharma

    Astellas Pharma has positioned itself strongly within the Nuclear Imaging Devices Market. It leverages its commitment to innovation and customer-centric solutions. The company has invested significantly in R&D, leading to the development of advanced nuclear imaging products.

    These products help in accurate diagnosis and treatment planning. Astellas Pharma benefits from a robust global presence, facilitating the distribution of its products across multiple regions. Its strengths lie in its strategic collaborations with healthcare institutions and continuous efforts to refine imaging technologies.

    Astellas Pharma's focus on enhancing diagnostic accuracy and efficiency contributes to its competitive edge. The company aims to address the evolving demands in the nuclear imaging sector, ensuring its prominent role in the market.

    Northwestern Medicine

    Northwestern Medicine is another pivotal player in the Nuclear Imaging Devices Market. It is known for its extensive range of imaging services and capabilities. The organization emphasizes high-quality patient care through state-of-the-art nuclear imaging technologies.

    These technologies assist in the diagnosis and monitoring of various medical conditions. Northwestern Medicine boasts a strong market presence, driven by its dedicated research initiatives and partnerships with other healthcare entities.

    The company’s strengths include its commitment to clinical excellence and innovation. This allows it to offer specialized nuclear imaging services that are critical for patient care and advanced diagnostics.

    Moreover, Northwestern Medicine has been involved in strategic mergers and acquisitions, which bolster its presence in the market and enhance its technological capabilities. This ensures that it remains a significant competitor in the global landscape of nuclear imaging devices.

    Key Companies in the Nuclear Imaging Devices Market market include

    Industry Developments

    The Nuclear Imaging Devices Market has seen significant dynamics in recent months. In September 2023, Siemens Healthineers announced the launch of its new molecular imaging platform, aiming to enhance diagnostic capabilities and patient outcomes.

    In August 2023, Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system with advanced imaging capabilities. This system is designed to improve diagnostic accuracy and workflow efficiency in clinical settings.

    In June 2023, Canon Medical Systems unveiled enhancements to its Celesteion PET/CT system. These enhancements focused on faster acquisition times and improved image reconstruction algorithms, which cater to the increasing demand for high-efficiency imaging solutions in oncology.

    Concurrently, GE Healthcare unveiled advancements in PET and SPECT technology, emphasizing a shift towards precision medicine in cancer treatment. Notable developments like these showcase the evolving landscape.

    Major companies like Philips, Canon Medical Systems, and Hitachi Healthcare are navigating competitive challenges while striving to deliver cutting-edge nuclear imaging solutions. This continuous innovation drives the market forward.

    Future Outlook

    Nuclear Imaging Devices Market Future Outlook

    The Nuclear Imaging Devices Market is projected to grow at a 4.38% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven imaging software to enhance diagnostic accuracy and efficiency.
    • Expand product offerings in emerging markets to capture untapped customer segments.
    • Invest in partnerships with healthcare providers for integrated imaging solutions.

    By 2035, the Nuclear Imaging Devices Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

    Market Segmentation

    Nuclear Imaging Devices Market End Use Outlook

    • Hospitals
    • Diagnostic Centers
    • Research Institutions

    Nuclear Imaging Devices Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Nuclear Imaging Devices Market Technology Outlook

    • Cobalt-60
    • Technetium-99m
    • Gallium-68

    Nuclear Imaging Devices Market Application Outlook

    • Cardiology
    • Oncology
    • Neurology
    • Thyroid Function

    Nuclear Imaging Devices Market Product Type Outlook

    • Single Photon Emission Computed Tomography
    • Positron Emission Tomography
    • Hybrid Imaging Systems

    Report Scope

    Report Attribute/Metric

    Details

    Market Size 2024

    3.36(USD Billion)

    Market Size 2035

    3.17 (USD Billion)

    Compound Annual Growth Rate (CAGR)

    4.38% (2025 - 2035)

    Report Coverage

    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

    Base Year

    2024

    Market Forecast Period

    2025 - 2035

    Historical Data

    2019 - 2024

    Market Forecast Units

    USD Billion

    Key Companies Profiled

    Astellas Pharma, Northwestern Medicine, United Imaging Healthcare, Esaote, ZONARE, Mindray, Hitachi Healthcare, GE Healthcare, Canon Medical Systems, Siemens Healthineers, Philips, Neusoft Medical Systems, Toshiba, Bruker

    Segments Covered

    Application, Product Type, End Use, Technology, Regional

    Key Market Opportunities

    Rising prevalence of chronic diseases, Technological advancements in imaging devices, Expanding healthcare infrastructure in emerging markets, Increasing demand for personalized medicine, Growing aging population requiring diagnostic services

    Key Market Dynamics

    Technological advancements, Increasing prevalence of diseases, Growing demand for personalized medicine, Rise in aging population, Expanding healthcare infrastructure

    Countries Covered

    North America, Europe, APAC, South America, MEA

    Market Size 2025 2.07 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Nuclear Imaging Devices market?

    The Nuclear Imaging Devices market is the expected increase in total market value of 3.17 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Nuclear Imaging Devices market?

    Nuclear Imaging Devices market size was valued at approximately 1.98 billion USD in 2024. This figure will reach 3.17 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Nuclear Imaging Devices market?

    Nuclear Imaging Devices market is expected to grow at a CAGR of 4.38% between 2025 and 2035.

    How much will the Nuclear Imaging Devices market be worth by 2035?

    Nuclear Imaging Devices market is expected to be worth of 3.17 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Nuclear Imaging Devices market perform over the next 10 years?

    Over the next 10 years the Nuclear Imaging Devices market is expected to shift from usd billion 1.98 to 3.17 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What is the projected market size for the Nuclear Imaging Devices Market by 2035?

    By 2035, the overall market is projected to reach 5.0 USD Billion.

    Which region is anticipated to hold the largest share of the Nuclear Imaging Devices Market in 2024?

    North America is expected to dominate the market with a value of 1.179 USD Billion in 2024.

    How much is the Oncology segment expected to contribute to the Nuclear Imaging Devices Market by 2035?

    The Oncology segment is projected to contribute 1.8 USD Billion to the market by 2035.

    What is the market size for the Neurology application in the Nuclear Imaging Devices Market in 2024?

    The Neurology application is valued at 0.8 USD Billion in 2024.

    Who are the major players in the Nuclear Imaging Devices Market?

    Key players include GE Healthcare, Siemens Healthineers, Philips, and Toshiba among others.

    1. (% SHARE)
    2. TO 2035 (USD Billions)

    Nuclear Imaging Devices Market Segmentation

    • Nuclear Imaging Devices Market By Application (USD Billion, 2019-2035)

      • Cardiology
      • Oncology
      • Neurology
      • Thyroid Function
    • Nuclear Imaging Devices Market By Product Type (USD Billion, 2019-2035)

      • Single Photon Emission Computed Tomography
      • Positron Emission Tomography
      • Hybrid Imaging Systems
    • Nuclear Imaging Devices Market By End Use (USD Billion, 2019-2035)

      • Hospitals
      • Diagnostic Centers
      • Research Institutions
    • Nuclear Imaging Devices Market By Technology (USD Billion, 2019-2035)

      • Cobalt-60
      • Technetium-99m
      • Gallium-68
    • Nuclear Imaging Devices Market By Regional (USD Billion, 2019-2035)

      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa

    Nuclear Imaging Devices Market Regional Outlook (USD Billion, 2019-2035)

    • North America Outlook (USD Billion, 2019-2035)

      • North America Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • North America Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • North America Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • North America Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • North America Nuclear Imaging Devices Market by Regional Type

        • US
        • Canada
      • US Outlook (USD Billion, 2019-2035)
      • US Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • US Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • US Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • US Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • CANADA Outlook (USD Billion, 2019-2035)
      • CANADA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • CANADA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • CANADA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • CANADA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
    • Europe Outlook (USD Billion, 2019-2035)

      • Europe Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • Europe Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • Europe Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • Europe Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • Europe Nuclear Imaging Devices Market by Regional Type

        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Spain
        • Rest of Europe
      • GERMANY Outlook (USD Billion, 2019-2035)
      • GERMANY Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • GERMANY Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • GERMANY Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • GERMANY Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • UK Outlook (USD Billion, 2019-2035)
      • UK Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • UK Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • UK Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • UK Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • FRANCE Outlook (USD Billion, 2019-2035)
      • FRANCE Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • FRANCE Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • FRANCE Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • FRANCE Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • RUSSIA Outlook (USD Billion, 2019-2035)
      • RUSSIA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • RUSSIA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • RUSSIA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • RUSSIA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • ITALY Outlook (USD Billion, 2019-2035)
      • ITALY Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • ITALY Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • ITALY Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • ITALY Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • SPAIN Outlook (USD Billion, 2019-2035)
      • SPAIN Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • SPAIN Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • SPAIN Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • SPAIN Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • REST OF EUROPE Outlook (USD Billion, 2019-2035)
      • REST OF EUROPE Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • REST OF EUROPE Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • REST OF EUROPE Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • REST OF EUROPE Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
    • APAC Outlook (USD Billion, 2019-2035)

      • APAC Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • APAC Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • APAC Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • APAC Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • APAC Nuclear Imaging Devices Market by Regional Type

        • China
        • India
        • Japan
        • South Korea
        • Malaysia
        • Thailand
        • Indonesia
        • Rest of APAC
      • CHINA Outlook (USD Billion, 2019-2035)
      • CHINA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • CHINA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • CHINA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • CHINA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • INDIA Outlook (USD Billion, 2019-2035)
      • INDIA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • INDIA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • INDIA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • INDIA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • JAPAN Outlook (USD Billion, 2019-2035)
      • JAPAN Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • JAPAN Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • JAPAN Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • JAPAN Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • SOUTH KOREA Outlook (USD Billion, 2019-2035)
      • SOUTH KOREA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • SOUTH KOREA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • SOUTH KOREA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • SOUTH KOREA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • MALAYSIA Outlook (USD Billion, 2019-2035)
      • MALAYSIA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • MALAYSIA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • MALAYSIA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • MALAYSIA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • THAILAND Outlook (USD Billion, 2019-2035)
      • THAILAND Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • THAILAND Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • THAILAND Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • THAILAND Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • INDONESIA Outlook (USD Billion, 2019-2035)
      • INDONESIA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • INDONESIA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • INDONESIA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • INDONESIA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • REST OF APAC Outlook (USD Billion, 2019-2035)
      • REST OF APAC Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • REST OF APAC Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • REST OF APAC Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • REST OF APAC Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
    • South America Outlook (USD Billion, 2019-2035)

      • South America Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • South America Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • South America Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • South America Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • South America Nuclear Imaging Devices Market by Regional Type

        • Brazil
        • Mexico
        • Argentina
        • Rest of South America
      • BRAZIL Outlook (USD Billion, 2019-2035)
      • BRAZIL Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • BRAZIL Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • BRAZIL Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • BRAZIL Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • MEXICO Outlook (USD Billion, 2019-2035)
      • MEXICO Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • MEXICO Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • MEXICO Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • MEXICO Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • ARGENTINA Outlook (USD Billion, 2019-2035)
      • ARGENTINA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • ARGENTINA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • ARGENTINA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • ARGENTINA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
      • REST OF SOUTH AMERICA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • REST OF SOUTH AMERICA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • REST OF SOUTH AMERICA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • REST OF SOUTH AMERICA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
    • MEA Outlook (USD Billion, 2019-2035)

      • MEA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • MEA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • MEA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • MEA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • MEA Nuclear Imaging Devices Market by Regional Type

        • GCC Countries
        • South Africa
        • Rest of MEA
      • GCC COUNTRIES Outlook (USD Billion, 2019-2035)
      • GCC COUNTRIES Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • GCC COUNTRIES Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • GCC COUNTRIES Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • GCC COUNTRIES Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • SOUTH AFRICA Outlook (USD Billion, 2019-2035)
      • SOUTH AFRICA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • SOUTH AFRICA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • SOUTH AFRICA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • SOUTH AFRICA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68
      • REST OF MEA Outlook (USD Billion, 2019-2035)
      • REST OF MEA Nuclear Imaging Devices Market by Application Type

        • Cardiology
        • Oncology
        • Neurology
        • Thyroid Function
      • REST OF MEA Nuclear Imaging Devices Market by Product Type

        • Single Photon Emission Computed Tomography
        • Positron Emission Tomography
        • Hybrid Imaging Systems
      • REST OF MEA Nuclear Imaging Devices Market by End Use Type

        • Hospitals
        • Diagnostic Centers
        • Research Institutions
      • REST OF MEA Nuclear Imaging Devices Market by Technology Type

        • Cobalt-60
        • Technetium-99m
        • Gallium-68

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials